摘要
Abstract
Objective To investigate the impact of Labetalol combined with Low Molecular Weight Heparin therapy on blood pressure and blood viscosity in pregnant women with pregnancy-induced hypertension.Methods A total of 548 pregnant women with pregnancy-induced hypertension admitted to Tengzhou Maternal and Child Health Hospital from January 2020 to December 2023 were selected as the study objects.All the pregnant women were divided into two groups using the method of random number table,with 274 cases in each group.The control group was treated with Labetalol,and the observation group was treated with Low Molecular Weight Heparin on the basis of the control group.The blood pressure,blood viscosity,umbilical artery resistance index,and coagulation indexes were compared between the two groups.Results After treatment,the systolic blood pressure and diastolic blood pressure decreased in both groups,and those in the observation group were lower than those in the control group(P<0.05).After treatment,the blood viscosity and umbilical artery resistance index of both groups were decreased,and those in the observation group were lower than those in the control group(P<0.05).After treatment,the fibrinogen of both groups was decreased,and that in the observation group was lower than that in the control group(P<0.05).The prothrombin time,activated partial thromboplastin,and thrombin time were increased in both groups,and those in the observation group were higher than those in the control group(P<0.05).Conclusion Labetalol combined with Low Molecular Weight Heparin therapy can effectively reduce the blood pressure and blood viscosity of pregnant women with pregnancy-induced hypertension,improve the hemorheology indexes and coagulation function.关键词
拉贝洛尔/低分子肝素/妊娠高血压综合征/血压/血液黏滞度Key words
Labetalol/Low Molecular Weight Heparin/Pregnancy-induced hypertension/Blood pressure/Blood viscosity分类
医药卫生
